Characteristics of hypertensive Canadians not receiving drug therapy

Canadian Journal of Cardiology

Volumn 24, Issue 6, 2008, Pages 485-490

  Campbell, Norman R C ^a,b   So, Lawrence ^a   Amankwah, Ernest ^a   Quan, Hude ^a   Maxwell, Colleen ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antihypertensive drugs; Health survey; Increased risk; Patient education

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CANADA; CARDIOVASCULAR RISK; CONSULTATION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HEALTH STATUS; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; ATTITUDE TO HEALTH; AWARENESS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HEALTH EDUCATION; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT; PREVALENCE; PROGNOSIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS;

ADULT; ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; AWARENESS; CANADA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH EDUCATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT DROPOUTS; POPULATION SURVEILLANCE; PREVALENCE; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 46249104579     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(08)70623-8     Document Type: Article

References (23)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005;365:217-23.
2. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002;287:1003-10.
3. World Health Organization. The World Health Report 2002. Geneva, Switzerland: World Health Organization, 2002.
4. Smith SC Jr, Blair SN, Criqui MH, et al. Preventing heart attack and death in patients with coronary disease. Circulation 1995;92:2-4.
5. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-9.
6. Onysko J, Maxwell C, Eliasziw M, Zhang JX, Johansen H, Campbell NR; Canadian Hypertension Education Program. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. Hypertension 2006;48:853-60.
7. Campbell NR, McAlister FA, Brant R, et al; Canadian Hypertension Education Process and Evaluation Committee. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens 2003;21:1591-7.
8. Campbell NR, Tu K, Brant R, Duong-Hua M, McAlister FA; Canadian Hypertension Education Program Outcomes Research Task Force. The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension 2006;47:22-8.
9. Neutel CI, Campbell NR. Antihypertensive medication use by recently diagnosed hypertensive Canadians. Can J Cardiol 2007;23:561-5.
10. Tu K, Campbell NR, Duong-Hua M, McAlister FA. Hypertension management in the elderly has improved: Ontario prescribing trends, 1994 to 2002. Hypertension 2005;45:1113-8.
11. Tobe SW, Touyz RM, Campbell NR; Canadian Hypertension Education Program. The Canadian Hypertension Education Program - a unique Canadian knowledge translation program. Can J Cardiol 2007;23:551-5.
12. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in western Europe and the United States. Arch Intern Med 2007;167:141-7. (Erratum in 2007;167:648).
13. Bleich SN, Cutler DM, Adams AS, Lozano R, Murray CJ. Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: Population based study. BMJ 2007;335:875-83.
14. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: A systematic review. J Hypertens 2004;22:11-9.
15. Greenberg JD, Tiwari A, Rajan M, Miller D, Natarajan S, Pogach L. Determinants of sustained uncontrolled blood pressure in a national cohort of persons with diabetes. Am J Hypertens 2006;19:161-9.
16. Agyemang C, van Valkengoed I, Koopmans R, Stronks K. Factors associated with hypertension awareness, treatment and control among ethnic groups in Amsterdam, the Netherlands: The SUNSET study. J Hum Hypertens 2006;20:874-81.
17. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997;10:1097-102.
18. Primatesta P, Poulter NR. Improvement in hypertension management in England: Results from the Health Survey for England 2003. J Hypertens 2006;24:1187-92.
19. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007;49:69-75.
20. Neutel CI, Campbell NR; Canadian Hypertension Society. Changes in lifestyle after hypertension diagnosis in Canada. Can J Cardiol 2008;24:199-204.
21. Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ 1992;146:1997-2005.
22. Wolf HK, Andreou F, Bata IR, et al. Trends in the prevalence and treatment of hypertension in Halifax County from 1985 to 1995. CMAJ 1999;161:699-704.
23. Khan NA, Hemmelgarn B, Padwal R, et al; Canadian Hypertension Education Program. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 - therapy. Can J Cardiol 2007;23:539-50.